UB Paderborn / Katalog / Suche / in CDI

IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial

The lancet oncology, 2016-11, Vol.17 (11), p.1599-1611

2016

Volltextzugriff (PDF)

Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention

World journal of urology, 2010-06, Vol.28 (3), p.247-252

2010

Volltextzugriff (PDF)

Doping of Graphene by Low-Energy Ion Beam Implantation: Structural, Electronic, and Transport Properties

Nano letters, 2015-08, Vol.15 (8), p.5110-5115

2015

Volltextzugriff (PDF)

Reference miRNAs for miRNAome analysis of urothelial carcinomas

PloS one, 2012-06, Vol.7 (6), p.e39309-e39309

2012

Volltextzugriff (PDF)

Long-Term Follow-Up of Peritoneal Interposition Flap in Symptomatic Lymphocele Reduction following Robot-Assisted Radical Prostatectomy: Insights from the PIANOFORTE Trial

Cancers, 2024-05, Vol.16 (10), p.1932

2024

Volltextzugriff (PDF)

Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas

International journal of biological sciences, 2012-01, Vol.8 (10), p.1363-1374

2012

Volltextzugriff (PDF)

Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta

American journal of physiology. Renal physiology, 2012-12, Vol.303 (12), p.F1592-F1598

2012

Volltextzugriff (PDF)

Ureteroenteric strictures: a single center experience comparing Bricker versus Wallace ureteroileal anastomosis in patients after urinary diversion for bladder cancer

BMC urology, 2019-10, Vol.19 (1), p.100-100, Article 100

2019

Volltextzugriff (PDF)

Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy

Clinica chimica acta, 2013-02, Vol.416, p.5-10

2013

Volltextzugriff (PDF)

Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma

BMC cancer, 2011-07, Vol.11 (1), p.295-295, Article 295

2011

Volltextzugriff (PDF)

In Reply

Deutsches Ärzteblatt international, 2017-03

2017

Volltextzugriff (PDF)

Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysis

BMC urology, 2012-05, Vol.12 (1), p.15-15, Article 15

2012

Volltextzugriff (PDF)

Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors

World journal of urology, 2010-10, Vol.28 (5), p.631-635

2010

Volltextzugriff (PDF)

Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer

BMC cancer, 2009-08, Vol.9 (1), p.276-276, Article 276

2009

Volltextzugriff (PDF)

Corrigendum to “The Epidemiology of Renal Cell Carcinoma” [Eur Urol 2011;60:615–21]

European urology, 2011-12, Vol.60 (6), p.1317-1317

2011

Volltextzugriff (PDF)

Reply from Authors re: Camillo Porta, Chiara Paglino. Experience Gathered from Retrospective Series on Renal Cell Carcinoma Is Useful, But Now It Is Time for a Global Claim for Academically Driven Prospective Studies. Eur Urol 2013;64:71–2

European urology, 2013-07, Vol.64 (1), p.72-73

2013

Volltextzugriff (PDF)

A Stent for Every Stone? Prestenting Habits and Outcomes from a German Multicenter Prospective Study on the Benchmarks of Ureteroroscopic Stone Treatment (BUSTER)

Urologia internationalis, 2020-06, Vol.104 (5-6), p.431-436

2020

Volltextzugriff (PDF)

Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer

Oncology reports, 2013-10, Vol.30 (4), p.1949-1956

2013

Volltextzugriff (PDF)

A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer

Journal of cancer research and clinical oncology, 2007-06, Vol.133 (6), p.343-349

2007

Volltextzugriff (PDF)

In Reply

Deutsches Ärzteblatt international, 2017-03, Vol.114 (9), p.160

2017

Volltextzugriff (PDF)

In Reply

Deutsches Ärzteblatt international, 2017-03, Vol.114 (9), p.160-160

2017

Volltextzugriff (PDF)

Correspondence (reply): In Reply

Deutsches Ärzteblatt international, 2017-03, Vol.114 (9), p.160-160

2017

Volltextzugriff (PDF)

Acucise endopyelotomy: A technique with limited efﬁcacy for primary ureteropelvic junction obstruction in adults

International journal of urology, 2005-10, Vol.12 (10), p.864-868

2005

Volltextzugriff (PDF)

Metabolic profiling reveals key metabolic features of renal cell carcinoma

Journal of cellular and molecular medicine, 2011-01, Vol.15 (1), p.109-118

2011

Volltextzugriff (PDF)

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma

European journal of cancer (1990), 2012-05, Vol.48 (7), p.1023-1030

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial

Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention

Doping of Graphene by Low-Energy Ion Beam Implantation: Structural, Electronic, and Transport Properties

Reference miRNAs for miRNAome analysis of urothelial carcinomas

Long-Term Follow-Up of Peritoneal Interposition Flap in Symptomatic Lymphocele Reduction following Robot-Assisted Radical Prostatectomy: Insights from the PIANOFORTE Trial

Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas

Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta

Ureteroenteric strictures: a single center experience comparing Bricker versus Wallace ureteroileal anastomosis in patients after urinary diversion for bladder cancer

Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy

Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma

In Reply

Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysis

Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors

Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer

Corrigendum to “The Epidemiology of Renal Cell Carcinoma” [Eur Urol 2011;60:615–21]

Reply from Authors re: Camillo Porta, Chiara Paglino. Experience Gathered from Retrospective Series on Renal Cell Carcinoma Is Useful, But Now It Is Time for a Global Claim for Academically Driven Prospective Studies. Eur Urol 2013;64:71–2

A Stent for Every Stone? Prestenting Habits and Outcomes from a German Multicenter Prospective Study on the Benchmarks of Ureteroroscopic Stone Treatment (BUSTER)

Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer

A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer

In Reply

In Reply

Correspondence (reply): In Reply

Acucise endopyelotomy: A technique with limited efﬁcacy for primary ureteropelvic junction obstruction in adults

Metabolic profiling reveals key metabolic features of renal cell carcinoma

Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma

Aktive Filter

Suchergebnisse filtern